<DOC>
	<DOCNO>NCT00976066</DOCNO>
	<brief_summary>The purpose study determine whether GSK1521498 attache sit brain call mu-opioid receptor involve liking reaction palatable high fat high sugar food . We hope block receptor may modify certain behaviour may lead obesity .</brief_summary>
	<brief_title>11CCarfentanil PET Study GSK1521498</brief_title>
	<detailed_description>This imaging study open-label , non-randomised PET receptor occupancy study healthy male volunteer . The degree time course μ-opioid receptor occupancy ( RO ) follow single oral dos GSK1521498 estimate [ 11C ] carfentanil displacement . Previous pre-clinical human PET study indicate [ 11C ] carfentanil selective μ-opioid receptor use estimate μ-opioid receptor occupancy vivo . The PK/PD relationship plasma concentration GSK1521498 μ-opioid RO described . Potential relationship μ-opioid RO functional magnetic resonance imaging ( fMRI ) endpoint , measure food reward paradigm , assess exploratory aim . Additionally , PK/PD relationships plasma concentration naltrexone ( generic μ-opioid receptor antagonist ) , μ-opioid receptor occupancy , fMRI measure reward processing also investigate .</detailed_description>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Carfentanil</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Healthy male subject age 25 65 year old inclusive . Body weight ≥ 50 kg BMI within range 18.5.0 30.0 kg/m2 ( inclusive ) . Normal ECG . The subject able read , comprehend record information . A signed date write informed consent obtain subject . Compliance birth control method describe study protocol . A subject eligible inclusion study follow criterion apply : The subject positive prestudy drug/alcohol screen . History hepatitis B /or C A positive result HIV test . Abnormal thyroid function Positive evaluation depression . History heavy alcohol use describe study protocol . The subject participate clinical trial receive investigational product within : 90 day . Participation drug study within calendar year . Use prohibit medication describe study protocol . History sensitivity study medication . Where participation study would result donation blood blood product excess 500 mL within 56 day period Unwillingness inability follow procedure outline protocol . Past present use tobacco product . Consumption red wine , seville orange , grapefruit grapefruit juice 7 day prior first dose study medication . Previous radiation dosage excess level acceptable take part study . History claustrophobia history neurological condition . Presence cardiac pacemaker . Works welder , metal worker machinist</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Naltrexone</keyword>
	<keyword>Carfentanil</keyword>
	<keyword>Receptor Occupancy</keyword>
	<keyword>mu-opioid Receptor</keyword>
	<keyword>PET ( Positron Emission Tomography )</keyword>
	<keyword>BOLD-fMRI</keyword>
</DOC>